Advanced search×

[Central nervous system involvement in primary Sjögren syndrome].

Med Clin (Barc) 133(9):349-59 (2009) PMID 19376547

Sjögren syndrome (SS) is a systemic autoimmune disease that affects the exocrine glands and presents with sicca symptoms of the main mucosa surfaces. The spectrum of the disease extends from sicca syndrome to systemic involvement (extraglandular manifestations). Although earlier studies described central nervous system (CNS) involvement as a frequent extraglandular manifestation of primary SS, symptomatic CNS involvement is rarely described in recent large series (<5%). A wide spectrum of neurological features has been described, including not only asymptomatic white matter lesions in MR examinations, but also severe focal or diffuse neurological processes. Differential diagnosis includes the coexistence of other systemic autoimmune diseases (lupus, antiphospholipid syndrome, vasculitis), cerebrovascular disease and multiple sclerosis.

DOI: 10.1016/j.medcli.2008.12.027
Version: za2963e q8za8 q8zb5 q8zc5 q8zdb q8ze9 q8zf5 q8zg2

Similar articles you may find interesting…

  1. [IgM antiphospholipical antibodies in preeclampsia-eclampsia].

    Cir Cir 71(6):449-54 (2003) PMID 14984669

    There were significant differences in levels of IgM and in weights and mortality among newborns between the two groups. In terms of maternal complications, we found HELLP syndrome as leading cause. We also observed in the case group significant differences in mean arterial pressure (MAP) and IgM lev...
  2. Subacute cutaneous lupus erythematosus and life-threatening hypokalaemic tetraparesis: a rare complication.

    Br J Dermatol 144(3):622-4 (2001) PMID 11260029

    We describe a patient with lesions of subacute cutaneous lupus erythematosus associated with high titres of anti-Ro and anti-La antibodies who developed a rapidly progressive flaccid tetraparesis due to profound hypokalaemia. After investigation she was found to have distal renal tubular acidosis (d...
  3. ANTI-CD3 therapy expands the numbers of CD4+ and CD8+ Treg cells and induces sustained amelioration of collagen-induced arthritis.

    Arthritis Rheum 62(1):171-8 (2010) PMID 20039431

    These results show that anti-CD3 mAb treatment has important therapeutic potential for rheumatoid arthritis and has the capacity to generate antiarthritic CD8+ Treg cells and expand the relative numbers of CD4+ Treg cells....